PT92995A - Metodo para o tratamento da disfuncao leucocita com gm-csf - Google Patents

Metodo para o tratamento da disfuncao leucocita com gm-csf

Info

Publication number
PT92995A
PT92995A PT92995A PT9299590A PT92995A PT 92995 A PT92995 A PT 92995A PT 92995 A PT92995 A PT 92995A PT 9299590 A PT9299590 A PT 9299590A PT 92995 A PT92995 A PT 92995A
Authority
PT
Portugal
Prior art keywords
dysfunction
csf
treating
leucocite
treatment
Prior art date
Application number
PT92995A
Other languages
English (en)
Other versions
PT92995B (pt
Inventor
Eric M Bonnem
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PT92995A publication Critical patent/PT92995A/pt
Publication of PT92995B publication Critical patent/PT92995B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • External Artificial Organs (AREA)
PT92995A 1989-01-30 1990-01-29 Metodo para o tratamento da disfuncao leucocita com gm-csf PT92995B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30439189A 1989-01-30 1989-01-30

Publications (2)

Publication Number Publication Date
PT92995A true PT92995A (pt) 1990-07-31
PT92995B PT92995B (pt) 1995-12-29

Family

ID=23176323

Family Applications (1)

Application Number Title Priority Date Filing Date
PT92995A PT92995B (pt) 1989-01-30 1990-01-29 Metodo para o tratamento da disfuncao leucocita com gm-csf

Country Status (21)

Country Link
US (1) US5178855A (pt)
EP (2) EP0455726A1 (pt)
JP (1) JPH0651640B2 (pt)
KR (1) KR0137361B1 (pt)
AT (1) ATE89737T1 (pt)
AU (1) AU633054B2 (pt)
CA (1) CA2045605C (pt)
DE (1) DE69001686T2 (pt)
DK (1) DK0382381T3 (pt)
ES (1) ES2055314T3 (pt)
FI (1) FI913625A0 (pt)
HK (1) HK46196A (pt)
HU (1) HU207229B (pt)
IE (1) IE64234B1 (pt)
IL (1) IL93219A (pt)
MY (1) MY105798A (pt)
NZ (1) NZ243953A (pt)
OA (1) OA09509A (pt)
PT (1) PT92995B (pt)
WO (1) WO1990008554A1 (pt)
ZA (1) ZA90600B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05506673A (ja) * 1991-02-22 1993-09-30 アムジエン・インコーポレーテツド 迅速な創傷の治癒を促進するためのｇｍ―ｃｓｆ及びｇ―ｃｓｆの使用
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
WO1994028919A1 (fr) * 1993-06-08 1994-12-22 Ajinomoto Co., Inc. Accelerateur de la proliferation des cellules hematopietiques
US5777193A (en) * 1994-03-04 1998-07-07 Ludwig Institute For Cancer Research Animals with targeted gene disruption
US5942253A (en) 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US7153943B2 (en) 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US6753165B1 (en) * 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
CA2673049C (en) * 2006-12-22 2016-02-23 Novadel Pharma Inc. Stable anti-nausea oral spray formulations and methods
US7826202B2 (en) * 2007-08-09 2010-11-02 Haworth, Inc. Modular electrical distribution system for a building

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
WO1987002060A1 (en) * 1985-10-03 1987-04-09 Biogen N.V. Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
DE3686582T2 (de) * 1985-11-27 1993-01-28 Genetics Inst Behandlung einer krankheit vom aids-typ.
DE3787020T2 (de) * 1986-05-06 1993-12-16 Genetics Inst Herstellung von m-csf.
US5162111A (en) * 1986-07-30 1992-11-10 Grabstein Kenneth H Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
EP0276846A3 (en) * 1987-01-29 1989-07-26 Zymogenetics, Inc. Colony-stimulating factor derivatives
IL88344A (en) * 1987-11-12 1994-06-24 Schering Corp Accelerating bone formation using a factor that accelerates colonies of granulocyte macrophages

Also Published As

Publication number Publication date
PT92995B (pt) 1995-12-29
OA09509A (en) 1992-11-15
IE900318L (en) 1990-07-30
IL93219A0 (en) 1990-11-05
FI913625A7 (fi) 1991-07-30
AU633054B2 (en) 1993-01-21
JPH03504980A (ja) 1991-10-31
MY105798A (en) 1995-01-30
DE69001686D1 (de) 1993-07-01
IE64234B1 (en) 1995-07-26
IL93219A (en) 1998-12-27
DK0382381T3 (da) 1993-07-12
JPH0651640B2 (ja) 1994-07-06
ES2055314T3 (es) 1994-08-16
CA2045605C (en) 1997-02-11
KR910700069A (ko) 1991-03-13
ZA90600B (en) 1990-10-31
CA2045605A1 (en) 1990-07-31
WO1990008554A1 (en) 1990-08-09
DE69001686T2 (de) 1993-09-02
ATE89737T1 (de) 1993-06-15
AU5048890A (en) 1990-08-24
NZ243953A (en) 1997-06-24
FI913625A0 (fi) 1991-07-30
KR0137361B1 (ko) 1998-04-25
US5178855A (en) 1993-01-12
EP0382381A1 (en) 1990-08-16
HK46196A (en) 1996-03-22
EP0455726A1 (en) 1991-11-13
HU207229B (en) 1993-03-29
HUT57607A (en) 1991-12-30
EP0382381B1 (en) 1993-05-26

Similar Documents

Publication Publication Date Title
PT911033E (pt) Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral
FI103180B (fi) Flurbiprofeenia sisältävien lääkkeiden valmistus kipujen ja/tai tulehd usten torjumiseksi eläimissä ja ihmisissä
ATE222770T1 (de) Pharmazeutische zubereitung für die subkutane, intramuskuläre oder intradermale verabreichung von faktor viii
ES2186693T3 (es) Uso combinado del acido hialuronico y de agentes terapeuticos para mejorar el efecto terapeutico.
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
PT97552A (pt) Processo para a preparacao de formas de dosagem para administracao de farmacos para o tratamento da doenca de parkison
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
DE69233760D1 (de) Inhibitoren der menschlichen Elastase von Neutrophilen
PT92995A (pt) Metodo para o tratamento da disfuncao leucocita com gm-csf
EP0317568A4 (en) Use of stimulation of granulocyte-macrophage colonies for obtaining a medicament for the treatment of bacterial diseases.
KR950701820A (ko) 패혈증 및 패혈증-연관 옹고장애의 예방 및 치료(prophylaxs and treatment of sepsis and sepsis-associated coagulation disorders)
ES2051710T3 (es) Utilizacion de d-fenfluramina para la fabricacion de medicamentos para el tratamiento de depresiones.
Bunchman II et al. Prevention and management of contractures in patients with burns of the neck
GR3032224T3 (en) Therapeutic agent for threatened abortion.
KR870010871A (ko) 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법
KR900701311A (ko) 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법
EP0397211A3 (en) Percutaneous administration of 3'-azide-3'-deoxythymidine
KR900700156A (ko) 개선된 방사선 치료법
ES2085411T3 (es) Uso de heptastigmina en la terapia de ictus cerebral.
周荣兴 et al. THE EFFECT OF ACUPUNCTURE ON THE PHAGOCYTIC ACTIVITY OF HUMAN LEUKOCYTES
Mayell Symposium. The burnt child and his family: RC MacKeith, D. MacG. Jackson, JM Woodward, and GF Vaughan. Proc. Roy. Soc. Med. 61: 1085–1088 (November), 1968
RU94001389A (ru) Способ лечения псориаза
IT9041714A0 (it) Linfa del libro dell'abete rosso (abies picea) per la cura di malattie neoplastiche e da virus in genere

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19950908

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20030331